Molecule Holdings Inc.
EVRRF · OTC
7/31/2023 | 4/30/2023 | 1/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $1 |
| % Growth | 328% | -57.4% | -22.7% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $1 |
| Gross Profit | $0 | $0 | -$0 | -$1 |
| % Margin | 35% | 1.4% | -34.5% | -111.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $1 | $1 |
| SG&A Expenses | $1 | $0 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $0 | $1 | $1 |
| Operating Income | -$0 | -$0 | -$1 | -$1 |
| % Margin | -43.8% | -166.6% | -138.3% | -258.7% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | -$0 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -110.2% | -527.8% | -174.9% | -291% |
| EPS | -0.01 | -0.009 | -0.007 | -0.015 |
| % Growth | -11.1% | -28.6% | 53.6% | – |
| EPS Diluted | -0.008 | -0.009 | -0.007 | -0.015 |
| Weighted Avg Shares Out | 79 | 98 | 98 | 98 |
| Weighted Avg Shares Out Dil | 98 | 98 | 98 | 98 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$1 | -$1 |
| % Margin | -32% | -208.8% | -136.5% | -226.4% |